Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function

Clinical trial NCT02304081 · COMPLETED

Trial details

NCT number: NCT02304081
Sponsor: Prof. Dr. Thomas Forst
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type2 Diabetes Mellitus

Start date: 2015-01-01
Primary completion: 2016-08-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.